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ABSTRACT 
Current treatment for type I diabetes includes delivery of insulin via injection or 
pump, which is highly invasive and expensive. The production of chloroplast-derived 
proinsulin should reduce cost and facilitate oral delivery.  Therefore, tobacco and lettuce 
chloroplasts were transformed with the cholera toxin B subunit fused with human 
proinsulin (A, B, and C peptides) containing three furin cleavage sites (CTB-PFx3). 
Transplastomic lines were confirmed for site-specific integration of transgene and 
homoplasmy. Old tobacco leaves accumulated proinsulin up to 47% of total leaf protein 
(TLP). Old lettuce leaves accumulated proinsulin up to 53% TLP. Accumulation was so 
stable that up to ~40% proinsulin in TLP was observed even in senescent and dried 
lettuce leaves, facilitating their processing and storage in the field. Based on the yield of 
only monomers and dimers of proinsulin (3 mg/g leaf, a significant underestimation), 
with a 50% loss of protein during the purification process, one acre of tobacco could 
yield up to 20 million daily doses of insulin per year. Proinsulin from tobacco leaves was 
purified up to 98% using metal affinity chromatography without any His-tag. Furin 
protease cleaved insulin peptides in vitro. Oral delivery of unprocessed proinsulin 
bioencapsulated in plant cells or injectable delivery into mice showed reduction in blood 
glucose levels similar to processed commercial insulin. C-peptide should aid in long-
term treatment of diabetic complications including stimulation of nerve and renal 
functions. Hyper-expression of functional proinsulin and exceptional stability in 
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dehydrated leaves offer a low cost platform for oral and injectable delivery of cleavable 
proinsulin.  
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INTRODUCTION 
Type 1 Diabetes 
 Type I Diabetes is an autoimmune disorder that results from the T-cells of the 
body’s immune system attacking the β-cells of the islets of Langerhans in the pancreas. 
It represents 5%-10% of all diabetes cases. However, type 1 diabetes accounts for over 
90% of diabetes cases in children (Giannini et al, 2009). As of 2007, it was reported that 
diabetes was the seventh leading cause of death in the US. The main etiology of Type I 
diabetes is a drop in insulin levels due to the destruction of the insulin-producing 
pancreatic β-cells, and therefore this leads to abnormally high blood glucose levels. This 
can lead to symptoms of the disease such as frequent urination, extreme hunger and 
thirst, weight loss, fatigue, and irritability. However, over time, sustained hyperglycemia 
leads to a number of other more serious complications such as heart disease, high 
blood pressure, kidney disease, and nervous system disease (National Diabetes Fact 
Sheet, 2008). It is these complications from diabetes that ultimately lead to death if left 
untreated.  
 Estimated annual costs in 2007 for diabetes care and other indirect costs for the 
United States alone totaled $174 billion with roughly $116 billion in excess medical 
expenditures comprised of $27 billion going to direct care, $58 billion to treat diabetic 
complications, and $31 billion in excess general medical costs. It is estimated that 
approximately $1 out of every $10 health care dollars is attributed to diabetes (American 
Diabetes Association, 2008). As the prevalence of diabetes worldwide continues to 
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increase, these costs are projected to be between $213 and $396 billion by the year 
2025 (Giannini et al, 2009). In many developing countries, the annual cost for insulin 
exceeds 50% of the average annual income. In developed countries, the cost of insulin 
alone is around $100 per month (Raab et al, 2004). Therefore, there is a great need to 
reduce the economic burden on people dealing with this disease.  
Insulin Production 
 Insulin is a 51 amino acid peptide hormone with a molecular weight of 5.8 kDa 
which is derived from its precursor, proinsulin. Proinsulin is produced in the pancreas as 
a 110 amino acid peptide containing a 24 amino acid signal sequence and the 86 amino 
acid proinsulin molecule consisting of the B chain (30 aa), C peptide (34 aa), and A 
chain (21 aa). During insulin biosynthesis in the pancreas, the C-peptide is cleaved off 
via the action of prohormone convertases 2 and 3 at the B chain/C-peptide and C-
peptide/A-chain junctions, respectively, and insulin (51 aa) is formed via disulfide bonds 
between the A and B chains (Shaw et al, 2002; Steiner, 1998). 
Commercial insulin production first began in 1922 and consisted of insulin 
harvested from bovine or porcine pancreas. Thirty years later, the gene for human 
insulin was sequenced, and by the 1970’s scientists were able to recreate the sequence 
in order to produce recombinant human insulin. This eliminated previous problems with 
adverse immune reactions from animal-derived insulin. Recently, insulin analogs such 
as insulin lispro and insulin aspart have been manufactured to contain amino acid 
alterations which increase absorption time (Levinson, 2003). Commercial preparations 
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of insulin are produced mainly in E. coli (Swartz, 2001) or yeast (Kjeldsen, 2000) as 
fusion proteins. In E. coli, The A chain and the B chain genes are introduced into two 
separate colonies, and the fusion peptides are produced individually. Then, the two 
chains are mixed together and joined by disulfide bonding. The resulting insulin is 
subsequently purified. Alternatively, insulin is produced from the proinsulin gene. 
However, C-peptide is removed from the final product. 
 Although insulin is predominantly made in bacteria or yeast for commercial 
production, there has been further research focusing on other methods for producing 
insulin including expression in plants. Earlier attempts at insulin expression in plant 
tissues have focused mainly on treating the autoimmune aspect of the disease by 
induction of oral tolerance. Both CTB-insulin produced in potato tubers (Arakawa et al, 
1998) and CTB fused with three copies of the insulin B chain expressed in the tobacco 
nuclear genome (Li et al, 2006) showed expression levels of only 0.1% of total soluble 
protein. A recent review article reports expression of various proinsulin constructs with 
or without C-peptide in Arabidopsis seeds that accumulated up to 1% total seed protein 
(Boothe et al, 2010). However, there is no reference for oral delivery of insulin 
expressed in plant cells, and there is a need to increase expression levels in large 
biomass crops in order to further advance this concept. 
Advantages of Chloroplasts 
 Chloroplast genetic engineering in plants offers several advantages over nuclear 
transformation. Some of these advantages include higher copy number and expression 
4 
 
levels of the transgene. Each chloroplast may contain up to 100 genomes, while each 
plant cell may contain up to 100 chloroplasts. Therefore, each plant cell may contain as 
many as 10,000 chloroplast genomes which results in high expression levels of proteins 
expressed via the chloroplast genome. Expression levels of up to 70% total soluble 
protein (Oey et al, 2009), and 72% total leaf protein (Ruhlman et al, 2010) of 
biopharmaceutical proteins have been reported in transgenic chloroplasts, which are the 
highest levels reported in published literature in this field. Chloroplasts offer gene 
containment through maternal inheritance, as the chloroplast genome is not transferred 
through pollen unlike nuclear genomic DNA (Daniell, 2007; Ruf et al, 2007). The 
chloroplast vectors are designed with flanking regions which are homologous to the 
chloroplast genome, and this prevents unwanted positional effects or gene silencing. 
Furthermore, chloroplasts have the ability to transcribe polycistronic RNA (Quesada-
Vargas et al, 2005) and can perform the correct processing of eukaryotic proteins 
including the ability to carry out post-translational modifications such as disulfide 
bonding, assembly of multimers, and lipid modifications (Arlen et al, 2007; Arlen et al, 
2008; Bally et al, 2008; Daniell et al, 2009a; Daniell et al, 2009b; Davoodi-Semiromi et 
al, 2009; Lee et al, in press). Finally, plants offer the benefit of low cost production of 
proteins and the protection of antigen via bioencapsulation (Arlen et al, 2008; Daniell et 
al, 2009b; Davoodi-Semiromi et al, 2009; Limaye et al, 2006; Verma and Daniell, 2007; 
Verma et al, 2008; Verma et al, 2010). These advantages make the chloroplast ideal for 
production of biopharmaceutical proteins and vaccines as well as an ideal vehicle for 
oral delivery. Several labs have successfully characterized the expression of 
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biopharmaceuticals such as alpha 1-antitrypsin (Nadai et al, 2009), insulin-like growth 
factor (Daniell et al, 2009a), Human serum albumin (Fernandez-San Milan et al, 2003), 
Human interferon alpha (IFNα2b) (Arlen et al, 2007), Cardiotrophin-1 (Farran et al., 
2008), Proinsulin (Ruhlman et al, 2007), and coagulation Factor IX (Verma et al, 2010). 
Ideally, expression of CTB-PFx3 in chloroplasts should provide a low-cost means to 
produce biologically functional insulin, which could be administered through both the 
injectable and oral delivery methods. Correct processing of proinsulin involves 
production of three intramolecular disulfide bonds, whereas CTB requires assembly into 
pentamers in order to be successfully absorbed into the circulation via the GM1 
receptors on the gut mucosa (Limaye et al, 2006). Chloroplasts are capable of 
performing necessary post-translational modifications which are essential for the 
functionality of CTB-PFx3 (Arlen et al, 2008; Bally et al, 2008; Daniell et al, 2009b; 
Davoodi-Semiromi et al, 2009; Lee et al, in press; Limaye et al, 2006; Verma et al, 
2010). 
Oral Delivery  
Oral delivery of biopharmaceutical proteins expressed in plant cells should 
reduce their cost of production, purification, processing, cold storage, transportation and 
delivery (Daniell, 2006). Efficient transformation of plastids of edible crops was recently 
achieved (Kanamoto et al, 2006 Kumar et al, 2004; Lelivelt et al, 2005; Ruf et al, 2001; 
Ruhlman et al, 2010), further facilitating the oral delivery of therapeutic proteins. The 
main challenges that arise from the concept of oral delivery of insulin are enzymatic 
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degradation in the stomach and absorption into the gastrointestinal tract (Agarwal and 
Khan, 2001). To overcome the first obstacle, human proinsulin with furin cleavage sites 
was engineered and introduced into the plant chloroplast. The plant cell wall naturally 
bioencapsulates proteins to prevent enzymatic degradation in the stomach (Daniell et 
al, 2009b; Davoodi-Semiromi et al, 2009). The antigen is then able to pass into the 
intestinal tract where it is subjected to mucosal immune responses. To overcome the 
second obstacle, the proinsulin construct was engineered to have the cholera toxin B 
(CTB) subunit fused to its N-terminus. CTB binds to GM1 receptors in the lumen of the 
gut (de Haan et al, 1998; Tsuji et al, 1995), and it has been shown that fusion to the C-
terminus of CTB is ideal for pentamerization and GM1 binding (Liljeqvist et al, 1997). It 
has been previously demonstrated that CTB facilitates uptake into the circulation via 
binding to the GM1 receptor located on the gut mucosa (Limaye et al, 2006). CTB-
conjugated proteins are then delivered to the GALT. Recently, CTB-FIX was 
successfully expressed and delivered orally to aid in treatment of hemophilia B. After 
delivery, the antigen was found in multiple tissues of the GALT, specifically the ileum, 
Peyer’s patches, liver, and plasma within two hours (Verma et al, 2010). 
C-Peptide 
The production of chloroplast-derived, orally-deliverable functional insulin should 
provide many benefits including a lower cost of production and the possibility of 
delivering the C-peptide which is currently lacking in commercially available insulin. This 
is of importance because type 1 diabetics fail to produce C-peptide, an essential 
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molecule which once was thought to be biologically inactive. C-peptide is located in 
between the B chain and A chain of the proinsulin molecule. Only recently, C-peptide 
has been shown to function independently of insulin. C-peptide acts via G-protein 
activation which signals the cell to open Ca2+ channels allowing for an influx of cellular 
Ca2+. This leads to stimulation of eNOS, Na+,K+-ATPase, and the MAP kinase pathway 
(Wahren, 2004). This action of C-peptide is thought to be the mechanism behind the 
beneficial effects seen upon restoration of C-peptide levels in type 1 diabetic animals 
and patients (Hills and Brunskill, 2009; Johansson et al, 2000; Sima and Li 2005). 
Stimulation of the activities of Na+,K+-ATPase and endothelial nitric oxide synthase 
(eNOS) is essential for nerve function (Ekberg et al, 2003; Wahren et al, 2007), and the 
stimulation of Na+,K+-ATPase also leads to correction of renal structure and function 
(Rebsomen et al, 2008). 
Furin Protease 
 Furin is an endoprotease present in the constitutive secretory pathway and cell 
surface of virtually all cells (Taylor et al, 2003). The consensus sequence for furin 
cleavage is the C-terminal arginine in the amino acid sequence Arg-X-Lys/Arg-Arg 
(Thomas, 2002). The introduction of furin consensus sequences at the B-chain/C-
peptide and the C-peptide/A-chain has been demonstrated to increase the processing 
of proinsulin to mature insulin in a wide variety of non-neuroendocrine cells, including 
fibroblasts, myoblasts, epithelial cells and lymphocytes (Croze and Prud’homme, 2003; 
Fujimoto et al., 2005; Groskreutz et al., 1994; Hay and Docherty, 2003; Ito et al., 2005; 
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Nishigori et al., 1996; Oh et al., 2006; Scougall et al., 2003; Scougall and Shaw, 2003; 
Shaw et al., 2002; Short et al., 1998; Tatake et al, 2007; Yamasaki et al., 1999; 
Yanagita et al., 1992; Yasutomi et al., 2003). In contrast, native proinsulin is processed 
in the pancreatic β-cells via prohormone convertases PC2/PC3. Non-neuroendocrine 
cells therefore do not possess the ability to process proinsulin into mature insulin. This 
processing is necessary for function of insulin, so addition of furin cleavage sites is 
necessary to facilitate processing in the gut. Although several different furin cleavage 
sites have been engineered, there seems to be the best processing (87%) of human 
proinsulin to unmodified mature human insulin using the RRKR furin cleavage sequence 
in adult fibroblasts (Shaw et al, 2002). Therefore, this is the sequence that has been 
engineered into our proinsulin constructs. Tobacco was used as a model system to 
quantify the production and facilitate the purification of CTB-PFx3 as well as monitor its 
functionality. Subsequentially, CTB-PFx3 was produced in lettuce for oral delivery 
studies. 
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MATERIALS AND METHODS 
Preparation and Transformation of Competent E. Coli Cells 
  Competent cells were created according to the method of Inoue et al (1990).  
Inoue transformation buffer (55mM MnCl2·4H2O, 15mM CaCl2·2H2O, 250mM KCl, 
10mM PIPES pH 6.7) was filter sterilized through a 0.45 μm Nalgene filter and stored at 
-20°C until ready for use. Meanwhile, XL-1 blue E. coli was inoculated in 3ml LB broth 
containing 7mg/L chloramphenicol and left to incubate overnight at 37°C. The next day, 
50 ml LB broth containing 1 ml of 1M MgCl2 was inoculated from the overnight culture 
and incubated under vigorous shaking at 37°C. Once the OD reached 0.4-0.6, the 
contents of the flask were cooled on ice for 10 minutes and then the cells were 
transferred to oakridge tubes and centrifuged at 3000rpm in a Sorvall rotor for 10 
minutes at 4°C. The medium was removed, and the cells were gently resuspended by 
swirling in 80 ml ice-cold Inoue buffer. Cells were spun under the same conditions, and 
the buffer was discarded. The cells were resuspended in 20 ml Inoue buffer, and 1.5 ml 
of DMSO was added slowly. The cells were mixed by swirling and incubated on ice for 
10 minutes. 200μl aliquots of the suspension were then quickly dispensed into chilled, 
sterile eppendorf tubes, snap-frozen in liquid nitrogen, and stored at -80°C. 
  For transformation, competent cells were thawed on ice and split into 100μl 
aliquots in pre-chilled 14 ml polypropylene round bottom tubes (Falcon). 3μl of the 
plasmid DNA was added to the cells and incubated on ice for 30 minutes. Cells were 
then heat shocked in a 42°C water bath for 45 seconds and rapidly returned to ice for 3 
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minutes. Cells were spun for 1 minute at 5000 rpm and the pellet was resuspended in 
800μl SOC media, warmed for 3 minutes in a 37°C water bath, and then incubated for 2 
hours at 37°C in a shaker. 100μl of cells was spread onto LB agar plates containing 
50mg/L ampicillin. The remaining cells were centrifuged at 5000 rpm for 2 minutes and 
all but 100μl of the supernatant was removed. The cells were resuspended in the 
remaining media and spread on the LB/Amp plates. All plates were incubated at 37°C 
overnight. 
Vector Construction 
  The CTB-PFx3 construct was created from pLD-5’UTR-CTB-Pins as previously 
described (Ruhlman et al, 2007). The Proinsulin gene was modified in order to include 
furin cleavage sites in between the B-chain/C-peptide and the C-peptide/A-chain 
junctions as well as between the CTB/B-chain fusion site. The pLD-5’UTR-CTB-Pins 
vector was digested with NcoI and SmaI and the resulting portion containing the 5’UTR 
was ligated into the pGEM-Pris(fx3) vector containing the mutated proinsulin. This was 
subsequently digested with EcoRI and NotI and subcloned into the pLD-g10-RecA 
vector, replacing the g10-RecA gene with the 5’Utr CTB-Pris(fx3) gene. The final vector 
was designated pLDutr-CTB-Fx3Pris. To create the lettuce vector, pLDutr-CTB-Fx3Pris 
was digested with SmaI and XbaI and the resulting Fx3Pris fragment was ligated into 
the 12.13.9.11 CTB-GPGP-FIX vector containing the lettuce-specific psbA 3’ and 5’ 
UTRs, replacing the FIX gene. To create the final vector, the pLspsbACTB-Fx3 Pris was 
digested with NdeI and NotI which was cloned into pLsLFHPAG vector containing the 
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lettuce flanking regions, and this vector was designated as pLsLF-CTB-Fx3Pris. After 
vector construction, the CTB-PFx3 genes were sequenced (GENEWIZ). Sequences 
were confirmed to be correct using BLAST search. 
Bombardment and Selection 
Seed Sterilization 
  Wild type Nicotiana tabacum cv. Petit Havana or Lactuca sativa cv. Simpson 
Elite seeds were sterilized in a disinfecting solution of 1.5% bleach and 0.1% Tween-20 
and grown on sterile Murashige and Skoog (MS) medium. Seeds were poured into an 
eppendorf tube and 1ml of 70% ethanol was added for 30 seconds. 1ml of disinfecting 
solution was added for 20 minutes with gentle tapping every 5 minutes. Seeds were 
then washed with 1ml of dH2O three times and then sprayed onto MS medium. After 
germination, plants were allowed to grow for ~3 weeks until large enough for 
bombardment. 
Preparation of Media 
  RMOP was made by dissolving 1 package of MS salts, 30g sucrose, 100mg 
myo-inositol, 1mg benzylaminopurine (BAP), 0.1mg α-naphthalene acetic acid (NAA), 
and 1mg thiamine hydrochloride made up to 1 liter in dH2O and brought to pH 5.8. 6g 
Phytoblend (Cassion Laboratories) was then added. For RMOL, this recipe was 
changed to 1 package of MS salts, 30g sucrose, 100mg myo-inositol 0.2mg BAP, 0.1mg 
NAA, 10mg thiamine hydrochloride, 1 mg pyridoxine hydrochloride, 1mg nicotinic acid, 
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and 1mg glycine made up to 1 liter in dH2O before bringing the pH to 5.8 and addition of 
phytoblend. 
Preparation of Gold Particles 
   Gold particles were vortexed at 4°C for 30 minutes. 6μg pLDutr-CTB-Fx3Pris or 
pLsLF-CTB-Fx3Pris was added for every 50μl of gold particles while vortexing. 
Additionally 50μl of 2.5M CaCl2 and 20μl of 0.1M spermidine were added per 50μl gold 
while vortexing. The mixture was vortexed for 5 minutes and then kept on ice for 2 
minutes. The gold preparation was then spun at 14,000rpm for 10 seconds. The clear 
supernatant was discarded, and the pellet was washed with 140μl 70% ethanol. The 
gold prep was again spun for 10 seconds at 14,000rpm and the supernatant discarded. 
Next, the prep was washed twice with 60μl cold 100% ethanol and kept on ice until use. 
Bombardment of Leaves  
  Bombardment was done using the Bio-Rad PDS-1000/He gene gun as described 
previously (Verma et al, 2008). Sterile tobacco leaves were placed abaxial side up 
whereas sterile lettuce leaves were placed abaxial side down on MS medium and were 
bombarded under sterile conditions using pLDutr-CTB-Fx3Pris or pLsLF-CTB-Fx3Pris 
coated with gold particles prepared according to Kumar and Daniell 2004. Sterile films 
were placed in the groove of the macro carrier and stop screen placed in the macro 
carrier holder. 7μl of the gold preparation was swirled onto the center of the film and let 
dry. Rupture discs of 1100 and 900 psi were used for bombardment of tobacco and 
lettuce, respectively.  
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Tissue Regeneration and Selection 
  Bombarded leaf pieces were incubated in the dark for 2 days at room 
temperature and then leaf pieces were transferred to regeneration media of plants 
(RMOP) containing 500mg/L spectinomycin for tobacco or regeneration media of lettuce 
(RMOL) containing 100mg/L spectinomycin (Ruhlman et al, 2010). The appearance of 
green shoots was seen after 4-6 weeks. These shoots were allowed to grow and the 
leaves were cut and subsequently transferred to RMOP or RMOL containing 500mg/L 
or 100mg/L spectinomycin, respectively, for the second round of selection. After new 
shoots formed, these were transferred for the third round of selection to MS containing 
500mg/L spectinomycin for tobacco or 100mg/L spectinomycin for lettuce and allowed 
to establish roots. Plants were then transferred to the greenhouse. 
PCR 
Total plant genomic DNA was extracted using the Qiagen DNeasy kit according 
to the manufacturer’s protocol. PCR was performed using primers corresponding to the 
3P (5’-AAAACCCGTCCTCAGTTCGGATTGC–3’) and 3M (5’CCGCGTTGTTTCATCAA 
GCCTTACG-3’) regions of the gene cassette in order to determine site-specific 
integration. The 3P primer anneals to the native chloroplast genome, and the 3M primer 
anneals to the aadA gene. PCR was also performed using the 5P (5’-CTGTAGAAGTCA 
CCATTGTTGTGC-3’)   and 2M (5’-TGACTGCCCACCTGAGAGCGGACA-3’) regions of 
the gene cassette in order to determine transgene integration. The 5P primer anneals to 
the aadA gene, and the 2M primer anneals to the native trnA gene (Verma et al 2008). 
14 
 
For lettuce, the primer 16 SF (5’-CAGCAGCCGCGGTAATACAGAGGA-3’), which also 
lands on the native chloroplast genome, was used in place of 3P.  Cycling parameters 
were as follows: 95°C for 5 minutes; 30 cycles of 95°C for 1 minute, 55°C (3P/16SF/3M) 
or 56.4°C (5P/2M) for 1 minute, and 72°C for 2 minutes; final extension at 72°C for 10 
minutes.  The reactions were held at 15°C and then run on a 1% agarose gel for 
visualization of bands.  
Southern Analysis 
DNA Extraction and Purification 
Total plant DNA was extracted using the cetyl trimethylammonium bromide 
(CTAB) method (Allen et al 2006) followed by phenol chloroform extraction to remove 
contaminating salts and proteins. DNA extraction buffer (DEB) was made with 2.5ml 1M 
Tris pH 8.0, 1ml 0.5M EDTA, 7ml 5M NaCl, 5ml 10% CTAB, 50μl β-mercaptoethanol, 
and brought up to 25ml with dH2O. 1ml of DEB was pre heated at 65°C for 15 min and 
then added to 100mg leaf tissue ground to a fine powder in liquid nitrogen. Samples 
were incubated at 65°C for 1 hour with intermittent mixing. Next, 2/3 volume 
chloroform:isoamyl alcohol (48:2) was added and tubes were mixed by gentle inversion 
for 20 minutes. Samples were centrifuged at 10,000 rpm for 10 minutes. The top layer 
was removed into a new tube and 2/3 volume cold isopropyl alcohol was added which 
precipitated the DNA. Samples were centrifuged for 10 minutes at 10,000 rpm and 
washed twice with 500μl 70% ethanol. The pellet was dried in a DNA Speed Vac 
(Savant) and subsequently dissolved in Tris-EDTA buffer (TE) containing 0.1 mg/ml 
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RNase. Samples were incubated at 37°C for 30 minutes and stored at 4°C until ready 
for phenol chloroform purification.  
Phenol chloroform purification was performed by adding an equal volume of 
phenol:chloroform:isoamyl alcohol (25:24:1) to the DNA sample followed by 
centrifugation at 12,000 rpm for 15 minutes. The upper layer was removed into a new 
tube and an equal volume of chloroform was added in order to remove phenol and 
inhibit DNA digestion. Samples were centrifuged for 15 minutes and the upper layer was 
again removed to a new tube. 1 ml chilled 100% ethanol and 1/10 volume 3M sodium 
acetate pH 5.2 was added and incubated at -20°C for 1 hour to precipitate the DNA. 
Samples were centrifuged for 10 minutes and the pellet was washed twice with 500μl 
70% ethanol. The DNA pellet was vacuum dried and resuspended in dH2O for Southern 
analysis.  
Restriction Digestion of Plant Genomic DNA  
Transgenic and untransformed tobacco DNA was digested using AflIII, and 
lettuce DNA was digested using BglII in a reaction containing 2μl 10X buffer (New 
England Biolabs), 3μg plant genomic DNA, 2μl BSA, and 1μl enzyme made up to 20μl 
with dH2O. The reactions were incubated overnight at 37°C. 
Agarose Gel Electrophoresis and DNA Transfer 
Southern analysis was performed according to lab protocol (Kumar and Daniell, 
2004). The entire 20μl restriction digestion samples were separated on a 0.8% agarose 
gel at 50V for 4h in Tris-acetic acid-EDTA (TAE) buffer. The gel was depurinated for 15 
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minutes in 0.25N HCl, rinsed 2 times for 5 minutes each in dH2O, and soaked in transfer 
buffer (0.4N NaOH, 1M HCl) for 20 minutes. All steps were performed with gentle 
rocking. DNA was transferred to a nylon membrane (Whatman) overnight on the 
benchtop. The gel was placed face down directly on a layer of plastic wrap followed by 
the membrane which was soaked for 5 minutes in transfer buffer, a piece of filter paper 
cut to the same size as the gel, then a stack of absorbent paper towels with a heavy 
weight on top. Parafilm was placed around the edges of the gel in order to prevent 
lateral transfer, and the transfer was allowed to take place over night. The next day, the 
membrane was rinsed with 2X SSC (0.3M NaCl, 0.03M Sodium Citrate) 2 times for 5 
minutes each and DNA was crosslinked to the membrane at 150 mJoule in GS Gene 
Linker (Bio-Rad).  
Generation and Labeling of Probes 
Flanking sequence probe was generated by digesting the pUC-CT vector (Verma 
et al, 2008) with BglII and BamHI in order to generate a 0.81kb fragment corresponding 
to the trnI/trnA region of the native chloroplast genome. Probe was labeled with 32P 
using Ready-to-Go DNA labeling beads (General Electric). 45μl of probe DNA was 
denatured by boiling for 5 minutes and then placed on ice for 2-3 minutes. DNA was 
briefly centrifuged and added to the Ready Mix tube along with 5μl 32P which was then 
incubated at 37°C in the radioactivity hood for one hour. A G50 column was vortexed to 
suspend the resin. The bottom plug was broken off and the column was spun at 3000 
rpm for one minute. The column was transferred to a new eppendorf tube and the probe 
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DNA was added and spun at 3000rpm for 2 minutes. The radioactivity of the probe was 
measured in a scintillation counter (X) in order to determine the proper amount of probe 
needed to hybridize to the membrane. 
Probe Hybridization and Audioradiography of Membrane 
The membrane containing the crosslinked DNA was placed in a cylindrical bottle 
with the top facing outward and the underside touching the wall of the bottle ensuring 
that no air bubbles were present between the bottle and the membrane. 10 ml of 
Stratagene Quick-Hyb solution was added to the bottle and incubated for 1 hour at 68°C 
in the rotating hybridization incubator (FisherBiotech). Meanwhile, 100μl of salmon 
sperm DNA was added to a fresh eppendorf tube. A calculated amount of labeled DNA 
probe was added and the mixture was boiled for 5 minutes. This solution was then 
added to the pre-hybridized membrane and incubated for 1 hour at 68°C. Next, the 
incubation temperature was brought down to 27°C to cool. The probe was saved or 
discarded and the membrane was washed twice with Wash I solution (2X SSC and 
0.1% SDS) for 15 minutes each at room temperature. Next, the membrane was washed 
twice with Wash II solution (0.1X SSC and 0.1% SDS) for 15 minutes each at 60°C. The 
radioactivity was checked with a Geiger Counter, and the membrane was wrapped in 
plastic wrap for audioradiography. The membrane was placed in a cassette and 
exposed to x-ray film from 4 hours up to 2 days at -80°C. When ready, the cassette was 
removed from the freezer and allowed to thaw before the film was removed in the dark 
room and placed in the developer.  
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Bradford Assay 
 Young, mature, and old leaf tissue was ground to a fine powder in liquid nitrogen 
using a mortar and pestle. 500µl of plant extraction buffer (100mM NaCl, 200mM Tris-
HCl pH 8.0, 0.1% Triton-X, 400mM sucrose, and Roche complete mini protease 
inhibitor cocktail tablet) was added to 100mg of frozen leaf tissue and vortexed for 
10min at 4°C. Plant tissue homogenates were further separated into supernatant and 
pellet fractions via centrifugation (14000 rpm for 5 min at 4°C), and the pellet was 
resuspended in 500µl plant extraction buffer for analysis. Total leaf protein 
concentration was determined using the Bio-Rad protein assay dye reagent 
concentrate. Dye was diluted 1:5 in water and filtered through Whatman filter paper. 
The standard curve was made using 0.4mg/ml BSA serially diluted down to 0.006mg/ml. 
Plant homogenate, supernatant, and pellet samples were diluted in water 1:5, 1:10, 1:20 
and 10ul of sample and BSA standard were loaded in duplicate to a 96 well plate. 200µl 
of diluted Bio-Rad dye was added to each sample and standard and the plate was read 
on a plate reader at 595nm. 
SDS-PAGE and Immunoblot Analysis 
Homogenate, supernatant, and pellet samples were diluted in 2X sample loading 
buffer (3.55 ml dH2O, 1.25 ml 0,5M Tris-HCl pH 6.8, 2.5 ml glycerol, 2 ml 10% SDS, 0.2 
ml 0.5% bromophenol blue) and loaded onto a 12% SDS-PAGE (Bio-Rad) gel. Samples 
were separated at 100-150V until the dye front reached the bottom of the gel. After 
separation, the gel was either stained with Coomassie Brilliant Blue R-250 (Bio-Rad) or 
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transferred to a nitrocellulose membrane (Bio-Rad) for immunoblot analysis. Transfer 
was carried out using a Bio-Rad transfer cassette at 85V for 1 hour. Membranes were 
briefly rinsed in dH2O and blocked in PBS-Tween-20 + 3% dry milk (PTM) for 30 
minutes to 1 hour. CTB-PFx3 was detected using anti-CTB primary antibody (Sigma) 
diluted 1:4000 for 1.5 hours followed by goat anti-rabbit IgG-HRP (Southern Biotech) at 
a dilution of 1:5000 for 1 hour. Proteins were subsequently detected on autoradiography 
film using SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific).  
Densitometric Quantification of CTBPFx3 
 Immunoblots for quantification were performed using known concentrations of 
CTB protein standard (Sigma) of 25, 50, 100, 200, and 400ng in order to create a 
standard curve. Total protein concentration was determined via the Bradford assay (Bio-
Rad). Varying concentrations of CTB-PFx3 plant homogenate were directly compared to 
the standard curve using Alphaimager and Alphaease FC software. The percentage of 
CTB-PFx3 relative to the concentration of total leaf protein and mg CTB-PFx3 per gram 
leaf tissue were calculated according to the formula published in Verma et al, 2008. 
Protein Solubilization and Furin Cleavage 
 CTB-PFx3 homogenate was separated into supernatant and pellet fractions. The 
pellet fraction containing the CTB-PFx3 in an insoluble form was resuspended in 1.5ml 
of plant extraction buffer per 100mg ground plant tissue along with 100-300mM 
dithiothreitol (DTT, Promega) and 6M Guanidine Hydrochloride (Gu-HCl, Sigma). 
Samples were rocked for 16-18h at 4°C. The samples were then centrifuged at 14,000 
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rpm for 5 minutes at 4°C, and the supernatant containing soluble CTB-PFx3 was 
separated from the pellet fraction. The sample was subsequently dialyzed using 
Spectra/Por molecularporous membrane tubing (Fisher Scientific) in 20mM sodium 
phosphate pH 7.8, 500mM NaCl overnight at 4°C. For cleavage with furin protease, 1µg 
of dialyzed sample was incubated with 100mM HEPES pH 7.5, 0.5% Triton X-100, 1mM 
CaCl2, 1mM 2-mercaptoethanol, and 2 units furin (New England Biolabs) at 25°C for 
16h. 
Affinity Purification 
  After solubilization and dialysis of the CTBPFx3, the resulting supernatant was 
passed over a column (Clontech) consisting of 2ml Ni-NTA Agarose (Qiagen) which 
was equilibrated with 20mM sodium phosphate pH 7.8 and 500mM NaCl (Binding 
buffer). The column was subsequently washed with 30ml binding buffer and then with 
30ml wash buffer (20mM sodium phosphate pH 6.0 and 500mM NaCl). Samples were 
eluted from the column in 1ml fractions using 10ml elution buffer (20mM sodium 
phosphate pH 6.0, 500mM NaCl, and 250mM imidazole). All steps were carried out at a 
flow rate of 0.5ml/min. Fractions were assayed for protein concentration via absorbance 
units at 280 nm using the SmartSpec 3000 (Biorad) and Bradford assay to determine 
the concentration in mg/ml. Purified CTB-PFx3 (1μg) was incubated with furin and cut 
and uncut samples were run on a 16% Tricine-SDS gel. Samples were also 
subsequently run on 12% SDS-PAGE gel and subjected to coomassie stain and 
immunoblot in order to determine the percent purity. 
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Sodium Phytate Precipitation 
Sodium phytate precipitation was done to remove Rubisco from purified samples. 
Purified samples were treated with 10mM CaCl2 and 10mM sodium phytate (phytic acid 
sodium salt hydrate from Sigma) for 10 minutes at 37°C. Afterwards, samples were 
spun in a tabletop centrifuge at room temperature for 10 minutes at 14,000rpm. 
Supernatant was removed, placed in a fresh tube, and stored at -20°C until use. 
Silver Stain 
  Tricine-SDS gel was incubated in fixative (45% dH2O, 45% methanol, 10% acetic 
acid) for 40 minutes. The gel was then washed with 50% methanol 2X for 5 minutes 
each and then with dH2O 2X for 5 minutes each. Next, the gel was rocked in Hypo 
solution (20mg Na2S2O3 in 100 ml dH2O) for exactly 1 minute and then washed in dH2O 
3X for 5 minutes each. Silver solution (200mg AgNO3 and 100μl formaldehyde in 100 ml 
dH2O) was added and the gel was rocked for 30 minutes. The gel was washed in dH2O 
4X for 5 minutes each and then developer solution (6g Na2CO3, 100μl of hypo, 100μl 
formaldehyde in 300 ml dH2O) was added. The gel was vigorously shaken in developer 
solution until protein bands appeared, and then the reaction was stopped by addition of 
5% acetic acid. 
Animal Studies to Determine Functionality 
  All procedures performed in this study are based on an approved protocol in 
accordance with UCF-IACUC. Female C57BL/6 mice weighing 17-20 grams each were 
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purchased from the Jackson Laboratories (Bar Harbor, ME). Mice were divided into four 
groups with 6 mice per group. Samples were prepared for delivery via IP injection by 
dilution in sterile PBS. Commercially purified insulin and purified CTB-PFx3 derived 
from transgenic tobacco were normalized via immunoblot and subsequently diluted to 
give each mouse a dosage of 0.04U/kg of commercially prepared insulin (Roche) and 
8µg/mouse of plant-derived purified CTB-PFx3. IP injections were delivered in a volume 
of 100μl. Blood glucose levels were measured by bleeding of the tail vein before sample 
administration and again at 15, 30, 60, 120, and 180 minutes after sample 
administration (Accu-Chek, Aviva). A second injection was given after 180 minutes and 
blood glucose measurements were taken at 15, 30, 60, 120, and 180 minutes after the 
second IP injection. Food pellets were removed for the duration of the study. For the 
oral study, female C57BL/6 mice were divided into four groups with 5 mice per group.  
Commercially purified insulin was diluted in sterile PBS and given at a dose of 0.04U/kg. 
IP injections were delivered in a volume of 100μl. Oral samples were prepared from 
material ground in liquid nitrogen and stored at -80°C until the day of the experiment. 
Prior to gavage, 3 grams of wild type and transgenic leaf material were mixed with 500µl 
20X PBS and homogenized using a General Laboratory Homogenizer (GLH-2596, 
Omni International) for five minutes. 200μl (~200mg) of leaf material containing 
approximately 0.5mg CTB-PFx3 was administered orally to mice via a 20 gauge gavage 
needle. Blood serum was taken by bleeding of the tail vein before sample administration 
and again at 15, 30, 60, 120, and 180 minutes after sample administration. A second 
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dose was given after 180 minutes and blood glucose measurements were taken at 15, 
30, 60, and 120 minutes after the second dose. 
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RESULTS 
Vector Construction 
  The CTB-PFx3 gene construct was inserted into the pLD vector as previously 
established by the Daniell lab (Verma and Daniell, 2007; Verma et al, 2008) or the 
pLsLF vector (Ruhlman et al, 2007; Ruhlman et al, 2010) under the control of the light-
regulated psbA region located within the 5’ UTR. Both vectors contain the aadA gene 
which confers resistance to spectinomycin and are driven by the upstream prrn 
promoter. Chloroplast vectors include native tobacco or lettuce DNA flanking regions 
(trnI/trnA) in order to facilitate homologous recombination. The CTB gene was 
separated from the proinsulin gene via a Glycine-Proline-Glycine-Proline (GPGP) hinge 
to avoid steric hindrance, followed by a furin cleavage site (RRKR) to enable removal of 
the CTB gene following delivery. Two additional furin cleavage sites were engineered at 
the B chain/C-peptide and the C-peptide/A chain junctions, replacing the native PC2 
and PC3 cleavage sites as previously described (Shaw et al, 2002). The location of 
engineered cleavage sites and disulfide bonds are compared with native proinsulin in 
Figure 1. The location of CTB fusion is also shown.  
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Figure 1: Location of Furin cleavage sites.  
(A) Native proinsulin. (B) Proinsulin molecule modified to contain furin cleavage sites 
and fused to CTB. 
26 
 
Chloroplast Transformation and Evaluation of Homoplasmy 
  Chloroplast vectors pLDutr-CTB-Fx3Pris and pLsLF-CTB-Fx3Pris were 
bombarded into tobacco and lettuce leaves, respectively. After 4-6 weeks, green shoots 
appeared and were subjected to 3 rounds of selection. Presence of the transgene was 
confirmed via PCR (data not shown), and homoplasmy was confirmed by Southern 
blots. Transformed and untransformed tobacco DNA was digested with AflIII and probed 
with a 0.81kb sequence complimentary to the trnI/trnA region of the native chloroplast 
genome. This produced a 4.2kb fragment in the untransformed tobacco (Figure 2A) and 
a 6.4kb fragment in the transplastomic tobacco (Figure 2B). Both transplastomic lines A 
and B showed only one hybridizing fragment of 6.4kb size, and did not show a fragment 
of the same size as the untransformed plant, indicating that all the chloroplast genomes 
had integrated the foreign gene and confirmed homoplasmy (Figure 2C).  
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Figure 2: Southern analysis of transgenic tobacco containing CTB-Proinsulin with three 
furin cleavage sites. 
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(A) Map of untransformed tobacco plastome. Digestion with AflIII yields a 4.2kb 
fragment. Broken line represents probe annealing site. (B) Map of transformed tobacco 
plastome. Digestion with AflIII yields a 6.4kb fragment. (C) Southern analysis from T1 
generation. A and B represent independent transplastomic lines. WT, untransformed 
plant. 
  Similarly, transformed and untransformed lettuce DNA was digested with BglII 
which produced a 3.75kb fragment in the untransformed lettuce (Figure 3A) and a 6.3kb 
fragment in the transplastomic lettuce (Figure 3B). Only the 6.3kb band was present in 
all transplastomic lines tested, confirming homoplasmy (Figure 3C). 
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Figure 3: Southern analysis of transgenic lettuce containing CTB-Proinsulin with three 
furin cleavage sites. 
(A) Map of untransformed lettuce plastome. Digestion with BglII yields a 3.75kb 
fragment. Broken line represents probe annealing site. (B) Map of transformed lettuce 
plastome. Digestion with BglII yields a 6.3kb fragment. (C) Southern analysis from T0 
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generation. 1, 2, 5, 6 and 8 represent independent transgenic lines. Lowercase letters a 
and b represent different samples from the same line. WT, untransformed plant. 
Detection and Quantification of Cleavable Proinsulin 
  Coomassie staining and immunoblotting were used to determine whether the 
transgenic plants were expressing CTB-PFx3. Transplastomic and untransformed 
young, mature, and old leaves were ground to a fine powder in liquid nitrogen and 
protein was extracted with the addition of 300-500μl plant extraction buffer. Young 
leaves are the new, light green, smaller leaves growing at the top of the plant. Mature 
leaves are large, dark green, and grow towards the middle of the plant. Old leaves are 
the bottom-most leaves that are beginning to turn brown (Figure 4).  
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Figure 4: Diagram of relative leaf ages in tobacco and lettuce plants. 
  Samples were spun down and the resulting supernatant, pellet, and homogenate 
fractions were collected and run on a 12% SDS-PAGE gel (Figure 5A). A polypeptide 
was seen at 22kDa in the pellet and homogenate fractions, but not in the supernatant, 
indicating that the CTB-PFx3 was expressed in the form of insoluble inclusion bodies. 
Immunoblots were performed using anti-CTB antibody to further confirm the presence of 
transgene expression. Young, mature, and old homogenate samples were loaded in 
equal volumes along with wild type homogenate and recombinant CTB protein (Figure 
5B). A prominent band at 22kDa represents the monomer size of the CTB-PFx3, but it is 
clear that the protein forms dimers, trimers, tetramers, pentamers, and multimers of 
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44kDa, 66kDa, 88kDa, and 110kDa sizes. Varying dilutions of the CTB-PFx3 
homogenate were loaded onto a 12% SDS-PAGE gel along with known concentrations 
of recombinant CTB protein, and spot densitometry was performed in order to quantify 
expression levels (Figure 5C). Different concentrations of CTB were loaded onto the gel 
in order to generate a standard curve (Figure 5D). CTB-PFx3 was expressed in levels 
up to 47% in old leaves (Figure 5E, Table 1) and as much as 2.92 mg/g leaf tissue 
(Figure 5F). 
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Figure 5: Characterization of CTB-Proinsulin expressed in tobacco chloroplasts. 
(A) Coomassie stain. M, marker; S, supernatant; P, pellet; H, homogenate; WT, 
untransformed plant. S&H: 30ug load. P: 7.5ug load. (B) Western blot probed with anti-
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CTB antibody showing CTB-PFx3 expression of young, mature, and old leaf total 
protein. 1µg per lane. CTB: 100ng CTB standard. (C) CTBPFx3 total protein was loaded 
in varying concentrations and compared to known quantities of CTB standard protein 
using densitometry. Blot was probed using anti-CTB antibody. (D) Plot of integrated 
density values (IDV) for quantification of CTBPFx3 based on standard curve. Broken 
line shows data points. Solid line: trend line. (E) Percent total protein for young, mature, 
and old leaves based on densitometry values. (F) Quantification of young, mature, and 
old leaves in mg CTBPFx3 per gram total leaf tissue. 
  Transgenic lettuce plants were prepared in the same way as tobacco, and 
varying dilutions of the samples were loaded onto a 12% SDS-PAGE gel for spot 
densitometric analysis of protein concentration (Figure 6A). Different concentrations of 
recombinant CTB protein was loaded onto the gel in order to create a standard curve 
(Figure 6B). Of the four lines tested, CTB-PFx3 was found to account for up to 53% of 
the total leaf protein (Figure 6C, Table 2) and as much as 3.28 mg/g leaf tissue (Figure 
6D, Table 2). The majority of expressed protein was found in the old leaves, and 
expression levels were comparable to levels observed in tobacco. 
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Figure 6: Characterization of CTB-Proinsulin expressed in lettuce chloroplasts. 
(A) CTBPFx3 total protein was loaded in varying concentrations and compared to 
known quantities of CTB standard protein using densitometry. Blot was probed using 
anti-CTB antibody. (B) Plot of integrated density values (IDV) for quantification of 
CTBPFx3 based on standard curve. Broken line shows data points. Solid line: trend 
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line. (C) Percent total protein for young, mature, and old leaves based on densitometry 
values. (D) Quantification of young, mature, and old leaves in mg CTB-PFx3 per gram 
total leaf tissue.   
 Additionally, due to the high levels of expression observed in old leaves, 
senescent and dried lettuce leaves were tested to investigate stability of CTB-PFx3. 
Senescent leaves that were completely brown and dry were harvested from 
transplastomic lettuce plants and protein was extracted as previously described. Leaf 
homogenate ranging from 0.125µg to 2µg total leaf protein was loaded on a 12% SDS-
PAGE gel and probed with CTB and insulin antibodies (Figure 7, A and B). High levels 
of expression up to 39% total leaf protein were detected even in senescent lettuce leaf 
material, further demonstrating that due to the insolubility of CTB-PFx3, it is highly 
stable and protected from proteolytic degradation. 
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Figure 7: Expression of CTB-Proinsulin in dried senescent lettuce leaves. 
(A) CTB-PFx3 total protein from dead leaf homogenate was loaded in 1 or 2 µg 
concentrations along with varying dilutions of CTB standard protein. Immunoblot was 
probed with anti-CTB antibody. (B) CTB-PFx3 total protein from dried leaf homogenate 
was loaded in 1 or 2 µg concentrations along with 100ng of insulin standard protein 
(shown in multimer form). Immunoblot was probed with anti-insulin antibody. 
Solubilization and Furin Cleavage of Proinsulin 
  To prepare the CTB-PFx3 for purification and cleavage assays, it was feasible to 
remove the protein as inclusion bodies and convert into a soluble form. Previously, in 
our lab, insoluble inclusion bodies of Human serum albumin (HSA) expressed in 
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tobacco chloroplasts were solubilized and successfully purified (Fernandez-San Millan 
et al, 2003). Solubilization was achieved using high quantities of Guanidine 
Hydrochloride (Gu-HCl) and DTT. DTT was added to plant pellet resuspended in plant 
extraction buffer containing 6M Gu-HCl. No CTB-PFx3 was found in the supernatant 
fraction after protein extraction, and this protein was entirely seen in the pellet fraction 
(Figure 8A). Addition of 100mM DTT achieved some solubility, but addition of 200 or 
300mM DTT achieved almost complete solubility of CTB-PFx3. Therefore, 300mM DTT 
was used for all subsequent solubilizations. After solubilization, the denatured protein 
was refolded in 20mM sodium phosphate pH 7.8 and 500mM NaCl. To determine if the 
engineered cleavage sites were functional, a furin cleavage assay was performed 
(Figure 8B). Upon addition of furin and immunoblot visualization with CTB antibody, it is 
seen that the 22kDa polypeptide representing the size of the CTB-PFx3 monomer 
disappears, and a polypeptide is seen at ~11kDa representing CTB alone as well as a 
polypeptide at ~14kDa which most likely represents an incomplete cleavage between 
CTB and proinsulin consisting of CTB fused to the B chain of proinsulin, with cleavage 
occurring at the B chain/ C peptide junction. The proinsulin 2-3kDa cleavage products 
were not detected by immunoblot with insulin antibody most likely due to the small size 
of the protein. Silver stain was performed to visualize the 2-3kDa products (Figure 8C). 
In this gel, the monomer of CTB-PFx3 is seen to fade after addition of furin, and a large 
band appears at the 2-3kDa size. One large band is visualized because the A chain, C 
peptide, and B chain cleavage products of proinsulin are 2kDa, 2.5kDa, and 3kDa 
respectively, which are too close in size to be resolved independently. 
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Figure 8: Solubilization and furin digestion of CTB-proinsulin.  
(A) Solubilization of CTB-PFx3 in 6M Gu-HCl. 5µg per lane. Lane 1, control pellet. Lane 
2, control supernatant. Lane 3, supernatant + 100mM DTT. Lane 4, pellet +100mM 
DTT. Lane 5, supernatant +200mM DTT. Lane 6, pellet +200mM DTT. Lane 7, 
supernatant +300mM DTT. Lane 8, pellet +300mM DTT. (B) Furin digestion of CTB-
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PFx3. CTB, 100ng CTB standard protein. –F, CTBPFx3 before furin cleavage. +F, 
CTBPFx3 after addition of furin. 1µg per lane. (C) Silver stained gel after affinity 
purification of CTBPFx3. Lane 1, precision plus ladder. Lane 2, Mark 12 low molecular 
weight ladder. Lane 3, purified CTBPFx3 1ug load. Lane 4, purified CTB-PFx3 after 
addition of furin. 1ug per lane. 
Purification and Enrichment of Proinsulin using Nickel Affinity Chromatography 
  Solubilized and dialyzed plant extracts containing CTB-PFx3 were passed over a 
Ni-NTA column to facilitate purification. Fractions were eluted and run on an SDS-PAGE 
gel and visualized by coomassie staining (Figure 9A). The 55kDa Rubisco large subunit 
is seen prominently in the wild type sample. This is typical as Rubisco is the most 
abundant protein in plants and probably the most abundant protein on earth (Jensen, 
2000). The 22kDa band of CTB-PFx3 is seen prominently in the control pellet (CP), but 
not in the control supernatant (CS), again showing that the protein is in the form of 
inclusion bodies. After solubilization and dialysis, CTB-PFx3 is detected in the dialyzed 
supernatant fraction (DS). Approximately 30ml of dialyzed supernatant were passed 
over the Ni-NTA column. No protein is seen to elute in the wash fractions (W1 and W2). 
The two eluted fractions with the highest optical density (OD) at 280nm were run on the 
gel. The 22kDa polypeptide representing CTB-PFx3 is seen prominently along with 
Rubisco, but it is seen that the contaminating protein bands are much less abundant; 
therefore, the total CTB-PFx3 protein content was purified and enriched compared to 
the starting material.  
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  Purification was repeated in order to achieve a greater level of purification by 
removing Rubisco. In order to enhance purification, old leaves were prepared in the 
same way as in the previous purification as they contain less Rubisco, and samples 
were run over a Ni-NTA column. After purification, additional Rubisco was removed 
using sodium phytate precipitation (Krishnan and Natarajan, 2009), and samples were 
loaded on an SDS PAGE gel for coomassie stain (Figure 9B). 
  The resultant purified fractions were loaded in equal quantity onto an SDS-PAGE 
gel for immunoblot analysis along with the dialyzed supernatant, flow through, and wash 
fractions. Blots were probed with either anti-CTB antibody (Figure 9C) or anti-insulin 
antibody (Figure 9D). In both blots, the purified CTB-PFx3 is shown to be highly 
enriched compared to the dialyzed supernatant. Additionally, the CTB-PFx3 monomer is 
enhanced, which would provide the functional, cleavable proinsulin. Densitometric 
analysis showed that the original dialyzed supernatant contained 27% CTB-PFx3, 
whereas after the first purification, this increased to an average of 57% purity (range 
determined by densitometry to be between 42% - 72%), a nearly 2-fold increase. After 
the second attempt at purification followed by sodium phytate precipitation, the sample 
was shown to be about 87% pure (range determined by densitometry to be between 
75% - 98%), over a 3-fold increase from the original dialyzed supernatant and a 1.5-fold 
increase from the first purification (Figure 9E). The starting concentration of the CTB-
PFx3 in the dialyzed supernatant was ~30,000ng/ml (0.03 mg/ml) which increased to 
~320,000ng/ml (0.32 mg/ml) after the first purification and to ~140,000ng/ml 
(0.14mg/ml) after the second purification representing a total enrichment greater than 
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10 fold and 4.5 fold, respectively (Figure 9F). The lower concentration in the second 
purification is most likely due to the fact that less total sample volume was loaded onto 
the column resulting in a lower concentration but achieving higher purity. 
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Figure 9: Purification of CTB-Proinsulin by affinity chromatography. 
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(A) Coomassie stained gel. DS = dialyzed supernatant; FT = flow through; W1 = wash 
1; W2 = wash 2; 2,3 = purified fractions; WT = wild type; CS = control supernatant; CP = 
control pellet (B) Coomassie stained gel showing second purification of CTB-PFx3: 
Lane 1: Marker. Lane 2: control pellet (before purification). Lane 3: Purified CTB-PFx3, 
Lane 4: Purified CTB-PFx3 after phytate precipitation to remove Rubisco. Lane 5: 
Control supernatant. All 10ug load. (C) 1µg of purified CTB-PFx3 samples was loaded 
using CTB primary antibody. DS = dialyzed supernatant; FT = flow through; W1 = wash 
1; W2 = wash 2; 2, 3 = purified fractions (D) 1µg of purified CTB-PFx3 samples was 
loaded using insulin primary antibody. DS = dialyzed supernatant; FT = flow through; 
W1 = wash 1; W2 = wash 2; 2, 3 = purified fractions (E) Densitometry shows that after 
purification, CTB-PFx3 makes up ~57% of the eluted fractions after the first purification 
and ~87% after the second purification as compared to ~27% of the dialyzed solubilized 
supernatant before passing over the nickel column. (F) The concentration of CTB-PFx3 
increases roughly 10 fold (~320000ng/ml) after the first purification and 4.6 fold 
(~140,000ng/ml) after the second purification over nickel column than the initial 
concentration of dialyzed solubilized supernatant (~30000ng/ml). 
Functional Evaluation of Cleavable Proinsulin 
 CTB-PFx3 purified from transplastomic tobacco as well as commercially 
produced purified insulin (Roche) was injected into female C57BL/6 mice along with 
PBS as a negative control. Blood glucose measurements were taken by tail vein bleed 
before intraperitoneal (IP) injection and at 15, 30, 60, 120, and 180 minute time 
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intervals. Another injection was given after the 180 minute time point, and blood glucose 
measurements were again taken at 15, 30, 60, 120, and 180 minute time points after 
the second injection. Blood glucose levels were found to be significantly lower than PBS 
control in all groups at the 120 minute time point after the second injection (Figure 10a), 
similar to commercial insulin. 
 Additionally, transplastomic lettuce and tobacco plants along with untransformed 
lettuce were delivered to mice by oral gavage. Commercially produced purified insulin 
was injected as a control. Blood glucose measurements were taken by tail vein bleed 
before gavage or injection and at 15, 30, 60, 120, and 180 minute time intervals. 
Another dose was given after the 180 minute time point, and blood glucose 
measurements were again taken at 15, 30, 60, and 120 minute time points after the 
second dose. Blood glucose levels were found to be significantly lower than 
untransformed control in all groups at the 120 minute time point after the second 
injection (Figure 10b). Food pellets were removed from cages for the duration of both 
studies. 
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Figure 10: Functional evaluation of CTB-Proinsulin in mice delivered by injection or oral 
gavage. 
ANOVA (Dunnett’s multiple comparison test) was performed on all groups of mice. (a) 
Mice were administered two IP injections of PBS only (PBS), purified CTB-PFx3 (Tg), or 
commercial Insulin (INS Comm.). Blood glucose levels were measured after the first 15 
minutes and each hour (up to three hours) after each injection. Blood glucose levels 
were statistically lower (**P<0.01) 2 hours after the second injection in all groups 
compared to the PBS only negative control. (b) Mice were administered two oral 
gavages of untransformed lettuce (WT), tobacco expressing CTB-PFx3 (Tg tobacco), 
lettuce expressing CTB-PFx3 (Tg lettuce), or two IP injections of commercial Insulin 
(INS Comm.). Blood glucose levels were measured after the first 15 minutes and each 
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hour (up to three hours) after each injection. Blood glucose levels were statistically 
lower (**P<0.01; ***P<0.001) 2 hours after the second injection in all groups compared 
to the untransformed (WT) control. 
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DISCUSSION 
Existing treatments for type 1 diabetes are painful, costly, and currently available 
insulin does not include the C-peptide. Here, we have expressed CTB-Proinsulin with 
three furin cleavage sites in both tobacco and lettuce chloroplasts in order to produce 
insulin that may be processed in any cell in the body. This will significantly reduce the 
cost of production, as well as facilitate the possibility of delivering the C-peptide which 
should aid in the treatment of diabetic complications. One acre of farm land can yield 
about 40 metric tons of tobacco with three harvests (Arlen et al, 2007) or 11 metric tons 
of lettuce biomass in a single harvest.  Assuming the expression level of CTB-PFx3 is 
around 3mg/g of leaf tissue, and taking into consideration a 50% loss of protein during 
the purification process, this would yield about 20 million daily doses of insulin. It is 
estimated that 220 million people worldwide have diabetes, 10% of these having type 1 
diabetes. Therefore, one acre of biomass could produce enough insulin to treat a large 
type 1 diabetic population, which would be a major economic advantage. 
There are many disadvantages to insulin injections which are currently the most 
widespread form of administration. These include, pain, itching, allergy, and 
lipodystrophy at the injection site. Additionally, these disadvantages often cause 
noncompliance of patients with their insulin regimen. Therefore, alternative approaches 
to insulin delivery are necessary to help diabetic populations meet their medical needs. 
Some of the recent approaches to address these problems include buccal spray insulin, 
inhalable insulin, oral anti-diabetic drugs, and oral delivery of insulin. Buccal spray 
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insulin is absorbed by the mucosa of the mouth and has a faster onset than injectable 
insulin. Limitations of this approach include a shorter duration of action and a dosage 
requirement that is 5-7 times higher than injectable insulin as well as mild side-effects 
such as dizziness (Pozzilli et al, 2010). Inhalable insulin faces similar challenges. The 
FDA approved inhalable insulin, Exubera, was pulled off the market due to poor sales 
and adverse side effects such as reduced lung function (Siekmeier and Scheuch, 2008). 
Oral anti-diabetic drugs are used mainly to treat type 2 diabetics as they improve insulin 
production, so there is still a need to deliver functional insulin to people with type 1 
diabetes and type 2 diabetics who require insulin. The main challenges that arise in 
advancing the concept of oral delivery of insulin are protection from enzymatic 
degradation in the stomach and efficient absorption into the GALT (Agarwal and Khan, 
2001). Approaches to overcome these challenges include encapsulation of insulin using 
nanoparticles and the delivery of insulin along with a protease inhibitor (Iyer et al, 2010). 
A novel approach to circumvent these obstacles is the expression of insulin in plant 
cells. 
Insulin has never been produced without a fusion protein as it is highly unstable 
and is prone to N-terminal degradation (Boothe et al, 2010). Therefore, we fused 
proinsulin with CTB in order to protect the N terminus of insulin from degradation as well 
as provide a means to facilitate purification and uptake of orally delivered insulin into the 
GALT. CTB binds to GM1 receptors in the lumen of the gut (de Haan et al, 1998, Tsuji 
et al, 1995), and it has been shown that fusion to the C-terminus of CTB is ideal for 
pentamerization and GM1 binding (Liljeqvist et al, 1997; Limaye et al, 2006). Recently, 
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CTB fused with blood clotting factor IX was successfully expressed and delivered orally 
to aid in treatment of hemophilia B. After delivery, the antigen was found in different 
tissues of the GALT, specifically the ileum, Peyer’s patches, liver, and plasma within two 
hours (Verma et al, 2010). Our CTB-proinsulin construct did not contain a His tag or any 
other tag to facilitate purification. However, CTB contains three histidine residues that 
are in close enough proximity when CTB is properly folded, which is enough to allow 
binding to anion exchange resins such as Ni2+ or Co2+ (Dertzbaugh and Cox, 1998). 
This way, purification of the CTB-PFx3 is facilitated by the CTB fusion. Additionally, 
purification is enhanced by the fact that a majority of the plant proteins are discarded 
with the supernatant, thus the initial sample to be purified contains only those proteins 
which were insoluble, eliminating a majority of endogenous plant soluble proteins. When 
expressed in plants, the insulin is also protected from enzymatic degradation in the 
stomach via bioencapsulation (Davoodi-Semiromi et al, 2010; Limaye et al, 2006; 
Verma et al, 2010). Therefore, advancing the concept of oral delivery of insulin by 
expressing it in plant cells should reduce its cost, facilitate purification and processing, 
eliminate the need for cold storage, and simplify transportation and delivery (Daniell et 
al, 2009b). 
Additionally, none of the alternative or currently used approaches to insulin 
delivery include the C-peptide. C-peptide is generally used as a marker to determine the 
extent of insulin release in patients. A large portion of diabetic patients who undergo 
extensive insulin therapy to maintain normal blood glucose levels still develop long-term 
complications such as neuropathy and nephropathy. C-peptide has been shown to 
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alleviate these complications in various studies, and this suggests that diabetic patients 
should receive supplemental C-peptide in addition to insulin (Hills and Brunskill, 2009).  
For these reasons, we have created cleavable proinsulin, which is able to be processed 
into properly folded and functional insulin as shown by functionality studies in mice. 
Upon cleavage, C-peptide is available for circulation, where it may interact with its G-
protein-coupled receptor and in turn activate the Na+/K+ ATPase and MAPK pathways, 
which are partly responsible for the beneficial effects seen in alleviating diabetic 
complications. This is the first time that the complete proinsulin gene has been 
expressed in plants with the possibility of in vivo processing outside the pancreas, into 
functional insulin and C-peptide.  
Upon hyper-expression of CTB-PFx3 in tobacco and lettuce chloroplasts, we 
noticed expression in the form of insoluble inclusion bodies, similar to insulin inclusion 
bodies observed in E. coli (Williams et al, 1982) or plants (Boothe et al, 2010). The 
functionality of CTB stems from its ability to pentamerize in order to bind to GM1 
receptors (Liljeqvist et al, 1997) and has been demonstrated to form functional 
pentamers in chloroplasts (Daniell et al, 2001; Limaye et al, 2006; Verma et al., 2010). 
Additionally, insulin and proinsulin may form self-aggregates of monomers, dimers, 
tetramers, and hexamers (Pekar and Frank, 1972) which may further contribute to their 
aggregation in chloroplasts. Furthermore, the majority of proinsulin accumulation was 
seen in older leaves as opposed to mature leaves, which is often observed among 
foreign (soluble) proteins expressed in chloroplasts (Daniell et al, 2001; Koya et al, 
2005; Arlen et al, 2008; Daniell et al, 2009a). This may account for the high levels of 
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expression seen in old leaves, as proinsulin may be protected from proteases which 
break down endogenous soluble leaf proteins with age (Martin and Thimann, 1972; 
Vierstra, 1993). Stability of CTB-PFx3 was even seen in senescent and dried leaves 
which should facilitate harvest, field drying, storage, and transportation of this valuable 
protein. This is the first report of stable accumulation of a therapeutic protein in dried 
senescent leaves.   
Quantification of total CTB-PFx3 expression in chloroplasts showed up to 47% 
and 53% in tobacco and lettuce old leaves, respectively. Attempts made to determine 
protein quantification by means of enzyme-linked immunosorbent assay (ELISA) were 
unsuccessful most likely due to the high quantity of protein aggregates which either 
inhibited binding to the ELISA plate or reduced the ability of the CTB primary antibody 
from binding to the proper epitopes on the CTB molecule. Addition of DTT to the sample 
extraction buffer or boiling of samples prior to coating of the ELISA plate with CTB-PFx3 
improved the detection of signal, but not enough to yield an accurate quantification. The 
denaturation of the CTB-PFx3 monomer and multimers during the immunoblot 
procedure most likely facilitated better binding of the CTB primary antibody, allowing 
access to the desired epitopes. For densitometry studies, only the monomer and dimer 
bands were used for the quantification, as the higher multimers tended to form less 
defined bands. Therefore, the percentages reported are likely an underestimation of the 
total expressed CTB-proinsulin. 
 Mice that were given oral CTB-PFx3 experienced changes in blood glucose 
levels but levels were significantly lower at 120 minutes after the second dose when 
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compared to mice given untransformed lettuce. This demonstrates that proinsulin is 
delivered to the circulation and is properly cleaved and folded. In a recently published 
study, we observed blood clotting factor IX fused with CTB in the circulatory system 2 
hours after oral delivery (the earliest time point in this study) of CTB-FIX expressed in 
chloroplasts (Verma et al, 2010).  Therefore, detection of plant-derived insulin activity in 
less than two hours is quite reasonable.  At this point,  the percentage of orally delivered 
protein absorbed by the GALT and delivered into the circulatory system has not been 
fully investigated, although several bioencapsulated chloroplast-derived therapeutic 
proteins have been orally delivered and shown to be fully functional.  Additionally, 
injected CTB-PFx3 must be processed into CTB and insulin when compared with the 
commercial insulin, which is already in its correct functional conformation. Therefore, 
determining the actual amount of CTB-PFx3 mice received and time required for 
processing would require further investigations.  
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CONCLUSIONS 
 This is the first time that the complete proinsulin gene has been expressed in 
plants with the possibility of in vivo processing outside the pancreas into functional 
insulin and C-peptide. It is also the first report of stable transgene expression present in 
senescent leaf tissue. There is a need for low-cost insulin as well as a need for 
developing oral insulin in order to avoid the pain and inconvenience associated with 
insulin delivery via injection or pump. Additionally, the currently available commercial 
insulin preparations do not include the C-peptide, which has been shown to alleviate 
diabetic complications such as neuropathy, nephropathy, and problems of the 
circulation. Proinsulin containing furin cleavage sites at the B chain/C-peptide and C-
peptide/A chain junctions was fused with CTB, and a furin cleavage site was present at 
the point of fusion. This was expressed in tobacco and lettuce chloroplasts at levels up 
to 47% and 53%, respectively, in old leaves. These high levels of expression led to the 
formation of insoluble inclusion bodies, which were solubilized using high 
concentrations of Gu-HCl and DTT. CTB-PFx3 was either orally delivered to mice or 
injected after purification, and results showed significant reduction in blood glucose 
levels as compared to negative controls. Future studies would investigate long-term 
effects of the C-peptide delivery on diabetic complications in addition to the effects of 
CTB-PFx3 on blood glucose levels. 
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